NEU 6.41% $15.27 neuren pharmaceuticals limited

A possibility worth worth contemplating, page-5

  1. 1,795 Posts.
    lightbulb Created with Sketch. 417
    Agree, POS. Also worth considering is that fact that FDA will already be well aware of the efficacy/safety of Trofentide with regards to RETT by the time TBI/Concussion results filter though. Jeez we will be looking at some big fireworks toward end of 2015
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.